2009CCO/PET成像用于小細(xì)胞肺癌診斷
《2009CCO/PET成像用于小細(xì)胞肺癌診斷》內(nèi)容簡(jiǎn)介：
What benefit to clinical management does positron emission tomography （PET） or positronemission tomography/computed tomography （PET/CT） contribute to the diagnosis orstaging of small cell lung cancer （SCLC）.
《2009CCO/PET成像用于小細(xì)胞肺癌診斷》內(nèi)容預(yù)覽：
What benefit to clinical management does PET or PET/CT contribute to the assessment oftreatment response for small cell lung cancer.
What benefit to clinical management does PET or PET/CT contribute when recurrence ofsmall cell lung cancer is suspected but not proven.
What benefit to clinical management does PET or PET/CT contribute to restaging at thetime of documented recurrence for small cell lung cancer.
What is the role of PET when a solitary metastasis is identified at the time of recurrenceand the metastectomy is being contemplated.
點(diǎn)擊下載***：《2009CCO/PET成像用于小細(xì)胞肺癌診斷》
本站所注明來(lái)源為"愛愛醫(yī)"的文章，版權(quán)歸作者與本站共同所有，非經(jīng)授權(quán)不得轉(zhuǎn)載。
本站所有轉(zhuǎn)載文章系出于傳遞更多信息之目的，且明確注明來(lái)源和作者，不希望被轉(zhuǎn)載的媒體或個(gè)人可與我們
聯(lián)系z(mì)lzs@120.net，我們將立即進(jìn)行刪除處理
熱點(diǎn)圖文
-
2013我國(guó)胰腺囊性腫瘤共識(shí)意見草案
本共識(shí)意見（草案）依據(jù)我國(guó)胰腺囊性腫瘤的最近研究，并參考國(guó)際相關(guān)指南和研究...[詳細(xì)]
-
2013NCCN結(jié)直腸癌指南
在美國(guó)，結(jié)直腸癌發(fā)病率占所有癌癥的第四位，而死亡率為第二位。2012年估計(jì)...[詳細(xì)]
